Literature DB >> 17035323

CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.

Elizabeth M Sitati1, Michael S Diamond.   

Abstract

Although studies have established that innate and adaptive immune responses are important in controlling West Nile virus (WNV) infection, the function of CD4(+) T lymphocytes in modulating viral pathogenesis is less well characterized. Using a mouse model, we examined the role of CD4(+) T cells in coordinating protection against WNV infection. A genetic or acquired deficiency of CD4(+) T cells resulted in a protracted WNV infection in the central nervous system (CNS) that culminated in uniform lethality by 50 days after infection. Mice surviving past day 10 had high-level persistent WNV infection in the CNS compared to wild-type mice, even 45 days following infection. The absence of CD4(+) T-cell help did not affect the kinetics of WNV infection in the spleen and serum, suggesting a role for CD4-independent clearance mechanisms in peripheral tissues. WNV-specific immunoglobulin M (IgM) levels were similar to those of wild-type mice in CD4-deficient mice early during infection but dropped approximately 20-fold at day 15 postinfection, whereas IgG levels in CD4-deficient mice were approximately 100- to 1,000-fold lower than in wild-type mice throughout the course of infection. WNV-specific CD8(+) T-cell activation and trafficking to the CNS were unaffected by the absence of CD4(+) T cells at day 9 postinfection but were markedly compromised at day 15. Our experiments suggest that the dominant protective role of CD4(+) T cells during primary WNV infection is to provide help for antibody responses and sustain WNV-specific CD8(+) T-cell responses in the CNS that enable viral clearance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035323      PMCID: PMC1676257          DOI: 10.1128/JVI.01650-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

Review 1.  T helper cell-dependent B cell activation.

Authors:  R J Noelle; E C Snow
Journal:  FASEB J       Date:  1991-10       Impact factor: 5.191

2.  In vitro T-cell proliferative response to the flavivirus, west Nile.

Authors:  A B Kulkarni; A Mullbacher; R V Blanden
Journal:  Viral Immunol       Date:  1991       Impact factor: 2.257

3.  Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells.

Authors:  K Murali-Krishna; V Ravi; R Manjunath
Journal:  J Gen Virol       Date:  1996-04       Impact factor: 3.891

4.  Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection.

Authors:  O L Wijburg; M H Heemskerk; A Sanders; C J Boog; N Van Rooijen
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

5.  Beta 2-microglobulin-deficient mice demonstrate class II MHC restricted anti-viral CD4+ but not CD8+ CTL against influenza-sensitized autologous splenocytes.

Authors:  S F Taylor; B S Bender
Journal:  Immunol Lett       Date:  1995-05       Impact factor: 3.685

6.  Dengue virus-specific, human CD4+ cytotoxic T lymphocytes generated in short-term culture.

Authors:  J Zivny; I Kurane; C O Tacket; R Edelman; F A Ennis
Journal:  Viral Immunol       Date:  1993       Impact factor: 2.257

7.  MHC II-restricted, CD4+ cytotoxic T lymphocytes specific for herpes simplex virus-1: implications for the development of herpetic stromal keratitis in mice.

Authors:  M Z Doymaz; C M Foster; D Destephano; B T Rouse
Journal:  Clin Immunol Immunopathol       Date:  1991-12

Review 8.  Immune responses in MHC class II-deficient mice.

Authors:  M J Grusby; L H Glimcher
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

9.  Analysis of murine major histocompatibility complex class II-restricted T-cell responses to the flavivirus Kunjin by using vaccinia virus expression.

Authors:  A B Kulkarni; A Müllbacher; C R Parrish; E G Westaway; G Coia; R V Blanden
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

10.  CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.

Authors:  A Oxenius; K A Campbell; C R Maliszewski; T Kishimoto; H Kikutani; H Hengartner; R M Zinkernagel; M F Bachmann
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  131 in total

Review 1.  Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe?

Authors:  Tian Wang
Journal:  J Neuroimmunol       Date:  2011-11-10       Impact factor: 3.478

Review 2.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

3.  NIAID workshop on Flavivirus immunity.

Authors:  Alison D Augustine; M Cristina Cassetti; Francis A Ennis; Eva Harris; William H Hildebrand; Patricia M Repik
Journal:  Viral Immunol       Date:  2010-06       Impact factor: 2.257

Review 4.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

5.  Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain.

Authors:  Erica L Beatman; Aaron Massey; Katherine D Shives; Kristina S Burrack; Mastooreh Chamanian; Thomas E Morrison; J David Beckham
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 6.  Current trends in West Nile virus vaccine development.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2014-04-01       Impact factor: 5.217

Review 7.  West Nile Virus: biology, transmission, and human infection.

Authors:  Tonya M Colpitts; Michael J Conway; Ruth R Montgomery; Erol Fikrig
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 8.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

9.  A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.

Authors:  Amelia K Pinto; Justin M Richner; Elizabeth A Poore; Pradnya P Patil; Ian J Amanna; Mark K Slifka; Michael S Diamond
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

10.  Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords.

Authors:  Alison J Johnson; Chin-Fun Chu; Gregg N Milligan
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.